Waymo is negotiating to raise $15 billion in funding, primarily from its parent company Alphabet, which could boost its valuation to $110 billion. The company currently operates or tests robotaxis in 26 markets and aims to expand its service significantly in the coming years.

Alphabet's AI drug discovery platform, Isomorphic Labs, has secured $600 million in funding from Thrive Capital. The investment aims to enhance the development of innovative therapies using advanced artificial intelligence techniques. This funding round highlights the growing intersection of AI and biotechnology in revolutionizing drug discovery processes.